Menu
Oncoguard Liver logo
  • PROVIDERS
    • Overview
    • The Oncoguard® Liver test
      • Clinical Performance
      • Scientific Rigor
      • Adding to the Workflow
      • Orders & Results
      • Insurance & Billing
    • Patient engagement program
    • Advocacy
    • About Us
    • Faqs
  • Patients
    • Liver Disease
      • Risk Factors
      • Detection & Monitoring
    • The Oncoguard® Liver Solution
      • The Oncoguard® Liver Test
      • Support
      • Advocacy
      • FAQs
    • About Us
  • EDUCATION
  • Resources
    • Ordering Information
    • Order Supplies
    • Forms
    • Specimen Collection
    • Implementation Guide
    • EpicCare® Link™
    • Advocacy
  • Contact US

Posts in: Featured

  • Featured
    From inception to practice— new insights from the development of a high-performance liquid biopsy test for the detection of early-stage HCC
  • Featured
    HCC surveillance: common goals, collective impact
  • Featured
    Evaluating an ALTernative to UltraSound: the ALTUS study for the surveillance of HCC
  • Masked nurse and older heavy set man
    Featured
    The COVID-19 pandemic reveals an opportunity to optimize the surveillance of HCC
  • Female dr and female patient
    Featured
    Hepatocellular carcinoma in the United States—HCV infection remains a threat, even as NAFLD increases
  • Shuttershock-1942361770
    Featured
    Improved Surveillance Is Urgently Needed to Help Reduce the Burden of Hepatocellular Carcinoma
  • ES-OGL-Blog
    Featured
    A simple blood test may detect HCC in its early stages, potentially improving patient outcomes
  • GettyImages-1153753610
    Featured
    Hepatocellular carcinoma is 10 times more likely to develop in the setting of nonalcoholic steatohepatitis than in simple fatty liver disease
  • GettyImages-120486268
    Featured
    Chronic liver disease is often a precursor to hepatocellular carcinoma
  • GettyImages-478187269
    Featured
    Early-stage hepatocellular carcinoma can be challenging to detect—it doesn’t have to be
  • GettyImages-961222214
    Featured
    We can improve hepatocellular carcinoma surveillance by understanding how risk factors are changing
  • Screen Shot 2021
    Featured
    Hepatocellular carcinoma has a high mortality rate—Improved surveillance may help reduce it

Sign up to be notified when a new blog is posted

exs-lvr-icon-blog-signup
Exact Sciences logo

Exact Sciences Corporation
5505 Endeavor Lane
Madison, WI 53719
Contact Us

Quick Links

  • About Exact Sciences
  • Licensing & Accreditations
  • Terms of Use
  • Privacy Policy
  • HIPAA Notice
  • Do Not Sell My Info

Follow us on

  • Facebook
  • Twitter
  • LinkedIn

Oncoguard is a registered trademark of Exact Sciences Corporation in the US. Epic and EpicCare Link are trademarks of Epic Systems Corporation. All third-party marks—®’ and ™’—are the property of their respective owners.

© 2022 Exact Sciences Corporation. All rights reserved. OL.00003 05/2022